drugset / Trial / NCT00034580

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

NCT00034580

Phase 4 Completed 326 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a research study comparing the safety and efficacy of two active study medications for the treatment of bipolar I disorder.

Timeline

Start
2001-08
Primary completion
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule
Subject Risperidone Other / unclassified

Indications